To promote the transformation and upgrading of Chinese medicine industry, we need to grasp the following 3 points

"
Pharmaceutical Network Industry Dynamic" Data show that since 2020
theof Chinese herbal medicine sandIn the first quarter, China's exports of Chinese herbal medicines and traditional Chinese medicines were close to 33,000 tons, up 10.3% YoY, while exports amounted to 1.88 billion yuan, up 3.2% YoYBut contrary to growing exports, 58 of the 68 listed Chinese medicine companies reported a year-on-year decline in net profit over the same periodTherefore, on the whole, the performance of Chinese medicine enterprises in 2020 is not very optimisticto promote the transformation and upgrading of the Chinese medicine industry, need to grasp the following three points
in fact, in recent years, China's medical reform began to be more in-depth, detailed implementation, the pharmaceutical industry is gradually beginning to be affected by many aspectsEspecially for Chinese medicine enterprises, because of the impact of a series of regulatory policies, many well-known varieties and enterprises have encountered a crisisIn this context, the call to promote the transformation and upgrading of the Chinese medicine industry is beginning to grow in the industryBut for Chinese medicine companies, most of them are still novices in the long-distance race to transform and upgradeIn the future, how to give full play to the advantages of Traditional Chinese medicine under the continuous strengthening of policy control and promote the transformation and upgrading of the industry will be a major challenge in the development of Chinese medicine enterprisesStrong and strong joint efforts to transform and expand other areas in recent years, with the reform of public hospitals into deep water, clinical control fees, key monitoring, Western medicine can not prescribe Chinese medicine and other policies, in order to prevent the abuse of traditional Chinese medicine, but also increased the performance pressure of Chinese medicine enterprises In this context, many well-known pharmaceutical companies, leading enterprises, or choose to join forces with state-owned enterprises, or the transformation to expand biopharmaceuticals, industrial cannabis and other fields such as one of the leading domestic Chinese medicine formula particles, in July 2018, together with Lanzhou Fuci Pharmaceuticals and Dingxi City, Gansu Province, Yanyuan County signed an investment cooperation agreement, in Weiyuan County to jointly build Chinese medicine refined beverage tablets and formula particle project Recently, two pharmaceutical companies jointly built a production base of Chinese medicine formula particles has started in Gansu Province It is expected that after the completion of the project, the annual treatment of Chinese herbal medicine up to 3000 tons, the annual output value of up to 1 billion yuan in addition to strong joint efforts, choose to expand other areas of Chinese medicine enterprises are also many In the case of industrial cannabis, on February 28 last year, Longjin Pharmaceuticals announced that it plans to increase its own capital by no more than 15 million yuan to Yunnan Pastoral Agriculture, and to acquire a 51% stake in it It is understood that the main business of pastoral agriculture is the large-scale cultivation of industrial cannabis, which in 2016 in the first time to obtain the Yunnan Province industrial cannabis cultivation license In December, Zixin Pharmaceuticals also signed the Framework Agreement on Strategic Cooperation in the Industrial Marijuana Industry With the People's Government of Gannan County, Qiqihar City, Heilongjiang Province, and the Market Supervision Administration of Qiqihar City, which will cooperate in the development of the industrial cannabis industry chain strengthen the level of intelligent manufacturing, improve efficiency and quality
with the advancement of the big health strategy, as well as the aging of people, health care awareness, consumption level upgrading, the traditional Chinese medicine industry to expand production capacity and technology upgrading needs are becoming more and more large In this context, the author found that in recent years, many pharmaceutical companies are planning or promoting the application of intelligent manufacturing in the Chinese medicine industry for example, pharmaceutical companies have introduced a fully automated digital Chinese medicine extraction workshop to improve production efficiency and quality Through information technology, the project establishes an integrated control system for production, supply and marketing, and can realize the automation of production process and digital traceability of product quality According to the pharmaceutical shop staff described, after the feeding staff only need to set the temperature, time, water, pressure and other parameters, and real-time observation can be Compared with the original production workshop, the intelligent workshop capacity increased 10 times, can achieve the annual processing of 3700 tons of medicinal herbs, the output value of finished products can reach about 3 billion yuan in addition, there are enterprises recently said on the interactive platform, its annual output of 4,340 tons of raw materials and 600 million chinese medicine extraction projects are currently steadily advancing, the company will promote the project as soon as possible to put into operation can be clearly found from the above, intelligent manufacturing for the Chinese medicine industry is of great significance, can further promote the transformation and upgrading of traditional Chinese medicine industry, improve efficiency and quality In the future, with the continuous improvement of the level of intelligence of Chinese medicine enterprises, or will help Chinese medicine to a broader international stage 　To strengthen the training and skills training of Chinese medicine personnel
in fact, the development of an industry can not be separated from the support of talents, and the transformation and upgrading is the same From the data, China has trained more than 2 million Chinese medicine talents in these years, but compared with the current large population base, the proportion is relatively small Therefore, through the domestic medical colleges to increase the training of Chinese medicine personnel, but also to reform the current method of training talents, so that the quality of talentmore in line with professional needs pharmaceutical companies can take a lot of measures, such as Yabao Pharmaceuticals has adopted two training methods, one is internal training, the other is external introduction In the internal training, it formed an internal trainer, according to the needs of the work to teach the staff, each employee every year to maintain 100 to 200 hours of school hours For middle-level cadres and bright-eyed employees, they are also allowed to study at Chinese medicine universities, and constantly improve their theoretical level, and then return to work in addition to , speed up the implementation of the university-oriented enrollment plan, the traditional Chinese medicine teacher inheritance plan and the grass-roots Chinese medicine personnel free training plan; in general, attract talent to join, improve the overall quality of staff, in order to have a complete talent echelon, the company can continue to innovate, improve quality, strengthen management, and create more and better drugs to serve the community.